Atlas Trials

Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer

Clinical trial NCT01611662 · TERMINATED

Trial details

NCT number
NCT01611662
Sponsor
Fox Chase Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Distal Urethral CancerProximal Urethral CancerSquamous Cell Carcinoma of the BladderStage II Bladder CancerStage III Bladder CancerUrethral Cancer Associated With Invasive Bladder Cancer
Start date
2012-05-29
Primary completion
2013-07-12
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.